Financials

v3.3.1.900
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Current Assets:    
Cash and cash equivalents $ 290,847 $ 252,145
Investment in trading securities 0 39,930
Prepaid expenses and other 354,415 158,849
Total Current Assets 645,262 450,924
Property and equipment, net 11,049 11,727
Intangible assets, net 318,547 357,540
Total Assets 974,858 820,191
Current Liabilities:    
Convertible notes payable - short term (see Note 5) 4,485,709 2,123,416
Accounts payable 1,219,867 1,064,480
Derivative liabilities 1,526,060 1,354,319
Accrued expenses and other 1,603,605 1,074,611
Total Current Liabilities 8,835,241 5,616,826
Stockholders' Deficit:    
Preferred stock Series A; $0.001 par value, 3,500,000 shares designated 150,611 and 949,477 shares issued and outstanding at December 31, 2015 and 2014, respectively (preference in liquidation of $125,007 at December 31, 2015) 152 951
Preferred stock Series B; $0.001 par value, 12,000,000 shares designated 5,382,071 and 5,694,571 hares issued and outstanding at December 31, 2015 and 2014, respectively (preference in liquidation of $5,347,550 at December 31, 2015) 5,382 5,695
Common stock - Class A - $0.001 par value, 100,000,000 shares authorized, 32,908,503 and 29,197,497 shares issued and outstanding at December 31, 2015 and 2014, respectively 32,910 29,199
Additional paid-in capital 24,705,547 24,034,203
Accumulated deficit (32,604,374) (28,866,683)
Total Stockholders' Deficit (7,860,383) (4,796,635)
Total Liabilities and Stockholders' Deficit $ 974,858 $ 820,191
v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Operating Expenses:    
General and administrative $ 2,465,478 $ 3,415,340
Research and development 720,861 1,753,500
Total Operating Expenses 3,186,339 5,168,840
Loss from Operations (3,186,339) (5,168,840)
Other Income (Expense):    
Interest income 0 18
Other income 0 6,864
Loss on disposition of intangible/fixed assets 0 (29,596)
Gain on settlement of accounts payable 184,039 11,126
Loss on sale of trading securities (11,946) (302,116)
Unrealized gain on trading securities 7,986 228,156
Gain on revaluation and modification of derivative warrant liability 715,962 1,227,998
Interest and other expense (873,359) (104,132)
Total Other Income, net 22,682 1,038,318
Loss Before Provision for Income Taxes (3,163,657) (4,130,522)
Provision for Income Taxes 0 0
Net Loss (3,163,657) (4,130,522)
Preferred Stock Dividend (574,034) (561,539)
Net Loss Attributable to Common Stockholders $ (3,737,691) $ (4,692,061)
Net loss per common share - Basic and Diluted $ (0.12) $ (0.16)
Weighted Average Shares Used in per Share Calculation - Basic and Diluted 30,038,240 28,641,197
v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (3,163,657) $ (4,130,522)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 46,365 42,470
Non-cash interest expense 511,362 44,388
Fair value of common stock issued for consulting 30,000 178,160
Fair value of warrants issued as covenant settlement 80,472 0
Share-based compensation related to stock options 135,492 417,569
Gain on accounts payable settlement (184,039) (11,126)
Loss on fixed asset dispositions 0 29,596
Net loss on sale of trading securities 11,946 302,116
Change in unrealized loss on trading securities (7,986) (228,156)
Gain on revaluation and modification of derivative liabilities (715,962) (1,227,998)
(Increase) decrease in:    
Prepaid expenses and other (113,247) (21,949)
Increase (decrease) in:    
Accounts payable 616,676 914,808
Accrued expenses and other 75,689 369,225
Net Cash Used by Operating Activities (2,676,889) (3,321,419)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale of investments 35,970 568,852
Cash paid for intangible assets 0 (350,000)
Cash paid for purchase of property and equipment (6,694) (6,564)
Net Cash Provided by Investing Activities 29,276 212,288
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of convertible notes payable - short term 2,980,005 1,928,000
Proceeds from other short - term financing 365,000 150,000
Notes payable issuance costs (168,690) (128,329)
Repayment of notes payable (490,000) (25,000)
Proceeds from the exercise of stock 0 90,375
Proceeds from sale of common stock, net 0 203,055
Net Cash Provided by Financing Activities 2,686,315 2,218,101
Net Change in Cash and Cash Equivalents 38,702 (891,030)
Cash and Cash Equivalents, Beginning of Period 252,145 1,143,175
Cash and Cash Equivalents, End of Period 290,847 252,145
Supplemental Cash Flow Disclosures:    
Interest expense paid in cash 3,543 0
Tax paid 1,912 1,412
Supplemental Non-Cash Disclosure:    
Fair value of warrants modified in connection with Series B financing 0 33,121
Fair value of warrants issued to Series B placement agents 0 12,738
Notes payable issued for securities 0 47,916
Notes payable issued as accounts payable settlement 0 22,500
Series B Preferred Stock dividend 453,305 466,966
Series A Preferred Stock dividend 47,602 77,403
Accounts Payable settled in Common Stock 277,250 0
Prepaid consulting services paid in Common Stock 30,000 0
Conversion of Series A Preferred Stock dividend to common stock 17,033 17,170
Conversion of Series A preferred shares to common stock 1,923 1,494
Conversion of Series B Preferred Stock dividend to Common Stock 56,094 1,254
Conversion of Series B preferred shares to common stock 313 50
Fair value of warrants issued as covenant settlement 80,472 0
Fair value of derivative warrants issued with Convertible Notes 358,255 0
Fair value of derivative warrants issued to Convertible Notes placement agents 39,108 0
Fair value of embedded derivative liability in Convertible Notes $ 490,340 $ 0